(MAIN) Main Street Capital - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US56035L1044

Private Equity, Mezzanine Debt, Senior Debt, Subordinated Debt, Preferred Equity

Stock: Asset Management & Custody Banks
Age 18.3y

MCap 5,730m
Avg Vol 501K (30.8M USD)

Beta 0.793
Volatility 21.80%

EPS (Earnings per Share)

EPS CAGR: -42.99%
EPS Trend: -9.9%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 8.46%
Rev. Trend: 71.0%

Last SUE: 0.80
Qual. Beats: 0

Dividends

Dividend Yield	7.57%
Yield on Cost 5y	21.35%
Yield CAGR 5y	13.21%
Payout Consistency	97.8%
Payout Ratio	24.3%

Risk via 5d forecast
Volatility	21.8%
Value at Risk 5%th	35.9%
Relative Tail Risk	0.18%

Reward TTM
Sharpe Ratio	0.48
Alpha	0.82
CAGR/Max DD	1.32

Character TTM
Hurst Exponent	0.439
Beta	0.793
Beta Downside	0.936

Drawdowns 3y
Max DD	20.97%
Mean DD	4.03%
Median DD	2.85%

Description: MAIN Main Street Capital January 09, 2026

Main Street Capital Corporation (NYSE: MAIN) is a publicly traded business development company that focuses on providing both private equity and private debt financing to lower-middle-market companies. It makes direct equity investments-ranging from control to non-control stakes-and offers a suite of debt solutions (senior secured, mezzanine, subordinated, and preferred equity) to support recapitalizations, growth capital, M&A, and refinancing across a broad industry spectrum.

As of the latest filing, MAIN reported $5.0 billion in total assets under management and generated a 7.2 % dividend yield, reflecting its BDC mandate to return cash to shareholders. The firm’s portfolio is weighted heavily toward logistics, industrial equipment, and health-care services-sectors that have benefited from post-pandemic supply-chain reshoring and rising demand for specialty medical devices. However, its performance remains sensitive to credit-cycle dynamics and interest-rate movements, which can affect both the cost of capital for borrowers and the valuation of its debt holdings.

For a deeper quantitative dive into MAIN’s valuation metrics and risk profile, you might find ValueRay’s analyst tools useful.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (536.5m TTM) > 0 and > 6% of Revenue (6% = 45.2m TTM)

FCFTA 0.07 (>2.0%) and ΔFCFTA 9.54pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -1.44% (prev 19.20%; Δ -20.64pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 396.0m <= Net Income 536.5m (YES >=105%, WARN >=100%)

Net Debt (2.12b) to EBITDA (554.8m) ratio: 3.82 <= 3.0 (WARN <= 3.5)

Current Ratio 0.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (89.2m) change vs 12m ago 1.99% (target <= -2.0% for YES)

Gross Margin 82.71% (prev 83.29%; Δ -0.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 14.51% (prev 13.37%; Δ 1.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 5.07 (EBITDA TTM 554.8m / Interest Expense TTM 130.2m) >= 6 (WARN >= 3)

Altman Z'' 1.36

(A) -0.00 = (Total Current Assets 30.6m - Total Current Liabilities 41.4m) / Total Assets 5.28b

(B) 0.09 = Retained Earnings (Balance) 481.7m / Total Assets 5.28b

(D) 0.21 = Book Value of Equity 482.6m / Total Liabilities 2.35b

Total Rating: 1.36 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 71.33

1. Piotroski 3.50pt

2. FCF Yield 5.04%

3. FCF Margin 52.58%

4. Debt/Equity 0.73

5. Debt/Ebitda 3.82

6. ROIC - WACC (= 5.32)%

7. RoE 18.73%

8. Rev. Trend 71.05%

9. EPS Trend -9.92%

What is the price of MAIN shares?

As of January 19, 2026, the stock is trading at USD 63.96 with a total of 400,267 shares traded.
Over the past week, the price has changed by +5.39%, over one month by +7.04%, over three months by +12.37% and over the past year by +12.94%.

Is MAIN a buy, sell or hold?

Main Street Capital has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold MAIN.

Strong Buy: 0
Buy: 0
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the MAIN price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	62.9	-1.7%
Analysts Target Price	62.9	-1.7%
ValueRay Target Price	81.2	27%

MAIN Fundamental Data Overview January 19, 2026

P/E Trailing = 10.5894
P/E Forward = 16.3132
P/S = 10.2087
P/B = 1.9526
P/EG = 2.09
Revenue TTM = 753.1m USD
EBIT TTM = 660.6m USD
EBITDA TTM = 554.8m USD
Long Term Debt = unknown (none)
Short Term Debt = 151.1m USD (from shortTermDebt, last fiscal year)
Debt = 2.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.12b USD (from netDebt column, last quarter)
Enterprise Value = 7.85b USD (5.73b + Debt 2.15b - CCE 30.6m)
Interest Coverage Ratio = 5.07 (Ebit TTM 660.6m / Interest Expense TTM 130.2m)
EV/FCF = 19.82x (Enterprise Value 7.85b / FCF TTM 396.0m)
FCF Yield = 5.04% (FCF TTM 396.0m / Enterprise Value 7.85b)
FCF Margin = 52.58% (FCF TTM 396.0m / Revenue TTM 753.1m)
Net Margin = 71.24% (Net Income TTM 536.5m / Revenue TTM 753.1m)
Gross Margin = 82.71% ((Revenue TTM 753.1m - Cost of Revenue TTM 130.2m) / Revenue TTM)
Gross Margin QoQ = 82.32% (prev 81.67%)
Tobins Q-Ratio = 1.49 (Enterprise Value 7.85b / Total Assets 5.28b)
Interest Expense / Debt = 1.51% (Interest Expense 32.5m / Debt 2.15b)
Taxrate = 7.29% (9.72m / 133.4m)
NOPAT = 612.5m (EBIT 660.6m * (1 - 7.29%))
Current Ratio = 0.74 (Total Current Assets 30.6m / Total Current Liabilities 41.4m)
Debt / Equity = 0.73 (Debt 2.15b / totalStockholderEquity, last quarter 2.93b)
Debt / EBITDA = 3.82 (Net Debt 2.12b / EBITDA 554.8m)
Debt / FCF = 5.35 (Net Debt 2.12b / FCF TTM 396.0m)
Total Stockholder Equity = 2.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.34% (Net Income 536.5m / Total Assets 5.28b)
RoE = 18.73% (Net Income TTM 536.5m / Total Stockholder Equity 2.86b)
RoCE = 12.60% (EBIT 660.6m / Capital Employed (Total Assets 5.28b - Current Liab 41.4m))
RoIC = 12.13% (NOPAT 612.5m / Invested Capital 5.05b)
WACC = 6.81% (E(5.73b)/V(7.88b) * Re(8.84%) + D(2.15b)/V(7.88b) * Rd(1.51%) * (1-Tc(0.07)))
Discount Rate = 8.84% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.78%
[DCF Debug] Terminal Value 75.98% ; FCFF base≈396.0m ; Y1≈259.9m ; Y5≈118.6m
Fair Price DCF = 9.33 (EV 2.95b - Net Debt 2.12b = Equity 835.5m / Shares 89.6m; r=6.81% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -9.92 | EPS CAGR: -42.99% | SUE: -4.0 | # QB: 0
Revenue Correlation: 71.05 | Revenue CAGR: 8.46% | SUE: 0.80 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=+0.008 | Revisions Net=+1 | Analysts=8
EPS next Year (2026-12-31): EPS=3.95 | Chg30d=+0.043 | Revisions Net=+1 | Growth EPS=+0.1% | Growth Revenue=+2.5%

Additional Sources for MAIN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle